Hemoglobin, lactate dehydrogenase, and facit-fatigue normalization rates in patients treated with pegcetacoplan: Results from the pegasus and prince phase 3 clinical trials

被引：0
|
作者：
Mulherin, B. [1 ]
Yeh, M. [2 ,3 ]
Al-Adhami, M. [3 ]
Savage, J. [3 ]
Dingli, D. [4 ]
机构：
[1] Hematol Oncol Indiana, Indianapolis, IN USA
[2] Ascension St Vincent Carmel, Carmel Valley, CA USA
[3] Apellis Pharmaceut, Waltham, MA USA
[4] Mayo Clin, Rochester, MN USA
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P272
引用
下载
收藏
页码：246 / 247
页数：2
相关论文
共 50 条
  • [31] Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials
    Dryden, Matthew
    Kantecki, Michal
    Yan, Jean Li
    Stone, Gregory G.
    Leister-Tebbe, Heidi
    Wilcox, Mark
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2022, 28 : 108 - 114
  • [32] Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE
    Dooley, M. A.
    Houssiau, F.
    Aranow, C.
    D'Cruz, D. P.
    Askanase, A.
    Roth, D. A.
    Zhong, Z. J.
    Cooper, S.
    Freimuth, W. W.
    Ginzler, E. M.
    LUPUS, 2013, 22 (01) : 63 - 72
  • [33] Predictors of New-Onset Diabetes in Patients Treated With Atorvastatin Results From 3 Large Randomized Clinical Trials
    Waters, David D.
    Ho, Jennifer E.
    DeMicco, David A.
    Breazna, Andrei
    Arsenault, Benoit J.
    Wun, Chuan-Chuan
    Kastelein, John J.
    Colhoun, Helen
    Barter, Philip
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : 1535 - 1545
  • [34] Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response—results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritis
    Proton Rahman
    Philip J. Mease
    Philip S. Helliwell
    Atul Deodhar
    Laure Gossec
    Arthur Kavanaugh
    Alexa P. Kollmeier
    Elizabeth C. Hsia
    Bei Zhou
    Xiwu Lin
    May Shawi
    Chetan S. Karyekar
    Chenglong Han
    Arthritis Research & Therapy, 23
  • [35] Bimekizumab Safety in Patients With Moderate to Severe Plaque Psoriasis Pooled Results From Phase 2 and Phase 3 Randomized Clinical Trials
    Gordon, Kenneth B.
    Langley, Richard G.
    Warren, Richard B.
    Okubo, Yukari
    Gold, Linda Stein
    Merola, Joseph F.
    Peterson, Luke
    Wixted, Krista
    Cross, Nancy
    Deherder, Delphine
    Thaci, Diamant
    JAMA DERMATOLOGY, 2022, 158 (07) : 735 - 744
  • [36] Responses to Ixekizumab in Male and Female Patients with Psoriatic Arthritis: Results from Two Randomized, Phase 3 Clinical Trials
    Lihi Eder
    Hans-Peter Tony
    Satish Odhav
    Eva Galindez Agirregoikoa
    Mariusz Korkosz
    Sergio Schwartzman
    Aubrey Trevelin Sprabery
    Amanda M. Gellett
    So Young Park
    Clinton C. Bertram
    Alexis Ogdie
    Rheumatology and Therapy, 2022, 9 : 919 - 933
  • [37] Responses to Ixekizumab in Male and Female Patients with Psoriatic Arthritis: Results from Two Randomized, Phase 3 Clinical Trials
    Eder, Lihi
    Tony, Hans-Peter
    Odhav, Satish
    Galindez Agirregoikoa, Eva
    Korkosz, Mariusz
    Schwartzman, Sergio
    Sprabery, Aubrey Trevelin
    Gellett, Amanda M.
    Park, So Young
    Bertram, Clinton C.
    Ogdie, Alexis
    RHEUMATOLOGY AND THERAPY, 2022, 9 (03) : 919 - 933
  • [38] CLINICAL OUTCOMES WITH MIGALASTAT IN PATIENTS WITH FABRY DISEASE BASED ON DEGREE OF RENAL IMPAIRMENT: RESULTS FROM PHASE 3 TRIALS
    Torra, Roser
    Germain, Dominique
    Bichet, Daniel
    Schiffmann, Raphael
    Yu, Julie
    Castelli, Jeffrey
    Skuban, Nina
    Barth, Jay
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [39] Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response-results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritis
    Rahman, Proton
    Mease, Philip J.
    Helliwell, Philip S.
    Deodhar, Atul
    Gossec, Laure
    Kavanaugh, Arthur
    Kollmeier, Alexa P.
    Hsia, Elizabeth C.
    Zhou, Bei
    Lin, Xiwu
    Shawi, May
    Karyekar, Chetan S.
    Han, Chenglong
    ARTHRITIS RESEARCH & THERAPY, 2021, 23 (01)
  • [40] Rimegepant for the Acute Treatment of Migraine in Patients with a History of Triptan Treatment Failure: Pooled Results From 3 Phase 3 Clinical Trials
    Jensen, Christopher
    Lipton, Richard
    Blumenfeld, Andrew
    Croop, Robert
    Thiry, Alexandra
    L'Italien, Gilbert
    Morris, Beth
    Coric, Vlad
    Goadsby, Peter
    NEUROLOGY, 2021, 96 (15)
12345